Phase 2 Nodal Marginal Zone Lymphoma Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma
Extranodal Marginal Zone Lymphoma
Izidore Lossos, MD35 enrolled1 locationNCT06569680
Recruiting
Phase 2
Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)
Marginal Zone LymphomaSplenic Marginal Zone LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+1 more
Izidore Lossos, MD25 enrolled1 locationNCT06796998
Recruiting
Phase 2
Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Recurrent Diffuse Large B-Cell LymphomaRecurrent Nodal Marginal Zone LymphomaRefractory Diffuse Large B-Cell Lymphoma+11 more
Joseph Tuscano25 enrolled1 locationNCT06905509